Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Eur J Pharm Sci. 2017 Mar 3;103:85–93. doi: 10.1016/j.ejps.2017.03.003

Table 1.

Lipid formulations and physical characterization.

Name Lipid Composition Molar Ratio Diameter (nm) PDI Zeta potential (mV)
HSPC HSPC:Chol:m-PEG-DSPE 51:44:5 125 0.04 −2.2
POPC 51 POPC:Chol:m-PEG-DSPE 51:44:5 132 0.06 −2.2
POPC 80 POPC:Chol:m-PEG-DSPE 80:15:5 110 0.06 −2.3
C8Chems C8Chems:m-PEG-DSPE 95:5 100 0.08 −2.4
C18.1Chems C18.1Chems:m-PEG-DSPE 95.5 115 0.04 −1.1
DChems DiChems:m-PEG-DSPE 95:5 130 0.09 −2.4
DChems/DPPC DiChems:DPPC:m-PEG-DSPE 32:63:5 119 0.1 −2.6